COVID-19's Impact on Measles Vaccination Coverage

More than 117 million children at risk of missing out on measles vaccines, as COVID-19 surges.

Statement by the Measles & Rubella Initiative comprised of the American Red Cross, U.S. Centers for Disease Control and Prevention, UNICEF, United Nations Foundation, and the World Health Organization. ATLANTA/GENEVA/NEW YORK, 14 April 2020:

As COVID-19 continues to spread globally, over 117 million children in 37 countries may miss out on receiving life-saving measles vaccines. Measles immunization campaigns in 24 countries have already been delayed; more will be postponed.

More than 117 million children around the world are at risk of missing measles vaccinations due to the COVID-19 pandemic.

During this challenging period, the Measles & Rubella Initiative (M&RI) expresses solidarity with families, communities, governments and emergency responders and joins our global immunization and health partners, including those within Gavi, the Vaccine Alliance and the Global Polio Eradication Initiative (GPEI) in our collective focus and fight against the threat of COVID-19. The pandemic sweeping the globe requires a coordinated effort and commitment of resources to ensure frontline health workers around the world are protected, as they face and respond to this new threat. At the same time, we must also champion efforts to protect essential immunization services, now and for the future.

The World Health Organization (WHO) has issued new guidelines endorsed by the Strategic Advisory Group of Experts on Immunization — to help countries to sustain immunization activities during the COVID-19 pandemic. The guidelines recommend that governments temporarily pause preventive immunization campaigns where there is no active outbreak of a vaccine-preventable disease. M&RI partners, which include the American Red Cross, the U.S. Centers for Disease Control and Prevention, UNICEF, the United Nations Foundation and WHO, strongly agree with these recommendations. We also urge countries to continue routine immunization services, while ensuring the safety of communities and health workers. The recommendations also ask governments to undertake a careful risk-benefit analysis when deciding whether to delay vaccination campaigns in response to outbreaks, with the possibility of postponement where risks of COVID-19 transmission are deemed unacceptably high.

If the difficult choice to pause vaccination is made due to the spread of COVID-19, we urge leaders to intensify efforts to track unvaccinated children, so that the most vulnerable populations can be provided with measles vaccines as soon as it becomes possible to do so. While we know there will be many demands on health systems and frontline workers during and beyond the threat of COVID-19, delivering all immunization services, including measles vaccines, is essential to saving lives that would otherwise be lost to vaccine preventable diseases.

Measles Immunization Campaigns in the Age of COVID-19

A masked Ethiopian worker prepares a measles vaccination shot.

Ethiopia's Successful Measles Campaign

June-July 2020

Ethiopia spearheads immunization in the age of COVID-19 with innovative approaches to keep workers and children safe. Over 14.5 million children vaccinated.


Status of Immunization Campaigns

September 2020
  • Measles immunization campaigns have been delayed or may be delayed in 41 countries in 2020.
  • As of 8 Sept 2020, only 5 countries have resumed immunization campaigns after initial delays.
  • >158 million people in 36 countries currently at risk for missing measles vaccination.
  • 16 of the 36 countries facing continued campaign delays have ongoing measles outbreaks.

The M&RI supports the need to protect communities and health workers from COVID-19 through a pause of mass campaigns, where risks of the disease are high. However, this should not mean that children permanently miss out. Urgent efforts must be taken now at local, national, regional and global levels to prepare to close the immunity gaps that the measles virus will exploit, by ensuring that vaccines are available and that they reach children and vulnerable populations, as quickly as possible, to keep them safe.

Despite having a safe and effective vaccine for over 50 years, measles cases surged over recent years and claimed more than 140,000 lives in 2018, mostly of children and babies – all of which were preventable. Against this already dangerous backdrop, preventive and responsive measles vaccination campaigns have now been paused or postponed in 24 countries to help avert further spread of COVID-19. Campaigns expected to take place later in 2020 in an additional 13 countries may not be implemented. Together, more than 117 million children in 37 countries, many of whom live in regions with ongoing measles outbreaks, could be impacted by the suspension of scheduled immunization activities. This staggering number does not include the number of infants that may not be vaccinated because of the effect of COVID-19 on routine immunization services. Children younger than 12-months of age are more likely to die from measles complications, and if the circulation of measles virus is not stopped, their risk of exposure to measles will increase daily.

The M&RI salutes the heroism of health and emergency workers across the globe, and we recognize the vital role they play in delivering clear, trusted information, as well as preventive and supportive care within their communities. We must invest in health workers and ensure they are protected from infection and empowered as part of sustainable and functioning primary health systems. They are the first line of defense against global epidemics. We also recognize the role of parents and caregivers in ensuring their children are vaccinated by following physical distancing recommendations in line with national guidance. Finally, we call on countries and local leaders to implement effective communication strategies to engage communities, ensure supply and demand for vaccination remains strong, and help assure a healthy life for every child especially in this challenging time.

About the Measles & Rubella Initiative
Partnership for Global Health

As a founding member of the Measles and Rubella Initiative (M&RI), launched in 2001, the U.S. Centers for Disease Control and Prevention provides both scientific and technical support to partners and countries to reduce measles and rubella-associated deaths, disease, and disabilities. In addition to the CDC, key partners include:

Page last reviewed: November 11, 2020
Content source: Global Immunization